Terms: = Leukemia AND IGL AND Prognosis
4 results:
1. Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL.
Chen H; Gu M; Liang J; Song H; Zhang J; Xu W; Zhao F; Shen D; Shen H; Liao C; Tang Y; Xu X
Nat Commun; 2023 Nov; 14(1):7468. PubMed ID: 37978187
[TBL] [Abstract] [Full Text] [Related]
2. 5' Rapid amplification of cDNA ends (5'RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia.
Lan X; Ruminy P; Bohers E; Rainville V; Viennot M; Viailly PJ; Etancelin P; Tilly H; Mihailescu S; Bouclet F; Leprêtre S; Jardin F
Leuk Res; 2022 Dec; 123():106952. PubMed ID: 36272389
[TBL] [Abstract] [Full Text] [Related]
3. BCL2 and MYC dual-hit lymphoma/leukemia.
Tomita N
J Clin Exp Hematop; 2011; 51(1):7-12. PubMed ID: 21628855
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.
Tomita N; Tokunaka M; Nakamura N; Takeuchi K; Koike J; Motomura S; Miyamoto K; Kikuchi A; Hyo R; Yakushijin Y; Masaki Y; Fujii S; Hayashi T; Ishigatsubo Y; Miura I
Haematologica; 2009 Jul; 94(7):935-43. PubMed ID: 19535347
[TBL] [Abstract] [Full Text] [Related]
